Chronic dysimmune neuropathies: Beyond chronic demyelinating polyradiculoneuropathy

scientific article

Chronic dysimmune neuropathies: Beyond chronic demyelinating polyradiculoneuropathy is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.4103/0972-2327.82789
P932PMC publication ID3141494
P698PubMed publication ID21808468
P5875ResearchGate publication ID51539657

P2093author name stringPramod D Dhonde
Satish V Khadilkar
Shrikant S Deshmukh
P2860cites workVasculitic neuropathy : clinical electrophysiological and histopathological charactersticsQ95477888
Length dependence of variables associated with temporal dispersion in human motor nervesQ30320992
Distal acquired demyelinating symmetric neuropathyQ33841623
Neuromuscular complications of connective tissue diseasesQ34141653
POEMS syndrome: definitions and long-term outcomeQ34161383
Chronic inflammatory demyelinating polyneuropathy accompanied by hepatocellular carcinoma.Q34738368
Transcutaneous cervical root stimulation in the diagnosis of multifocal motor neuropathy with conduction blockQ35476778
Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous systemQ35842193
Multifocal motor neuropathy: current concepts and controversies.Q36072147
Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatmentQ36480921
Anti-myelin-associated glycoprotein neuropathyQ36592059
Paraproteinemic neuropathyQ36745949
What's new in multifocal motor neuropathy in 2007-2008?Q37385090
Anti-GM2 IgM antibodies: clinical correlates and reactivity with a human neuroblastoma cell line.Q40946779
The systemic amyloidosesQ41596634
Diagnostic approach to central and peripheral nervous system vasculitisQ41641708
Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects, neurologic manifestations, and treatmentQ41641735
Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathyQ41663344
Multifocal motor neuropathy without overt conduction blockQ41702502
The sensitivity and specificity of anti-GM1 antibody testingQ42553258
Cladribine in the treatment of IgM paraproteinemic polyneuropathyQ44187817
Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteriaQ46619488
IVIg dose increase in multifocal motor neuropathy: a prospective six month follow-upQ48006982
Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trialQ48107965
Distinctive abnormalities of motor axonal strength-duration properties in multifocal motor neuropathy and in motor neurone diseaseQ48463928
The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathyQ48486772
Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatmentQ48536321
Activity-dependent conduction block in multifocal motor neuropathy: magnetic fatigue testQ48679319
How long is IVIg effective in multifocal motor neuropathy?Q51021985
Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy.Q51743176
What is the best diagnostic index of conduction block and temporal dispersion?Q53689960
Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study.Q53901414
Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance.Q53980487
A long-term study of prognosis in monoclonal gammopathy of undetermined significance.Q55035699
Neuronal antinuclear antibody in sensory neuronopathy from lung cancer.Q55060391
Motor Neuropathy with Proximal Multifocal Persistent Conduction Block, Fasciculations and MyokymiaQ56608957
Multifocal motor neuropathy: Is conduction block essential?Q56929758
Multifocal motor neuropathy with and without conduction block: A single entity?Q59243994
Neuropathy with onion bulb formations and pure motor manifestationsQ62803885
Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapyQ68075974
Visual evoked potentials in patients with neuropathy and macroglobulinemiaQ69015007
Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron diseaseQ69025264
Slow resolution of multifocal weakness and fasciculation: a reversible motor neuron syndromeQ69599049
A treatable multifocal motor neuropathy with antibodies to GM1 gangliosideQ69836574
Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron diseaseQ70035461
[Anti-Gm1 antibodies in motor system diseases and neuropathies]Q70251345
Nomenclature of amyloid and amyloidosis. WHO-IUIS Nomenclature Sub-CommitteeQ70577268
Conduction block and denervation in Guillain-Barré polyneuropathyQ71270566
Vasculitic neuropathy: profile of twenty patientsQ71272963
Persistent and transient "conduction block" in motor neuron diseasesQ72890170
Multifocal motor neuropathy presenting as ophthalmoplegiaQ73115212
Pulsed high-dose dexamethasone is not effective in patients with multifocal motor neuropathyQ73245639
Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatmentQ73298577
Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathyQ73343604
Natural history of 46 patients with multifocal motor neuropathy with conduction blockQ73864084
Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA platesQ73884492
Motor and sensory demyelinating mononeuropathy multiplex (multifocal motor and sensory demyelinating neuropathy): a separate entity or a variant of chronic inflammatory demyelinating polyneuropathy?Q74279484
Deterioration of multifocal motor neuropathy after plasma exchangeQ74575154
Chronic neuropathy with IgM anti-ganglioside antibodies: lack of long term response to rituximabQ75205847
Multifocal motor neuropathy: pathologic alterations at the site of conduction blockQ76387429
Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathyQ77292658
Are multifocal motor neuropathy and Lewis-Sumner syndrome distinct nosologic entities?Q77758992
Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndromeQ77758996
Upper limb predominant, multifocal chronic inflammatory demyelinating polyneuropathyQ77873391
Antiganglioside antibodies in multifocal acquired sensory and motor neuropathyQ78810728
Triple-stimulation technique in multifocal neuropathy with conduction blockQ79661913
Guidelines in electrodiagnostic medicine. Consensus criteria for the diagnosis of partial conduction blockQ80144059
Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndromeQ80407989
Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxiaQ80980704
Multifocal motor neuropathyQ81197431
Multifocal motor neuropathyQ81679400
P433issue2
P921main subjectpolyradiculoneuropathyQ3395796
P304page(s)81-92
P577publication date2011-04-01
P1433published inAnnals of Indian Academy of NeurologyQ4767851
P1476titleChronic dysimmune neuropathies: Beyond chronic demyelinating polyradiculoneuropathy
P478volume14

Reverse relations

cites work (P2860)
Q38312251A practical approach to enlargement of nerves, plexuses and roots
Q90151428Early Aggressive Immunotherapy Improves Functional Outcome in Chronic Immune Sensory Polyradiculopathy
Q34316260Pure Motor Axonal Neuropathy, Organomegaly, Impaired Glucose Tolerance, M Protein, Skin Changes, Multiple Plasmacytomas & Acute Interstitial Nephritis in Osteolytic Myeloma: Beyond POEMS!
Q38698738Utility of somatosensory evoked potentials in the assessment of response to IVIG in a long-lasting case of chronic immune sensory polyradiculopathy

Search more.